Rising awareness, increasing number of adolescent pregnancies, and government initiatives to promote hormonal contraceptives are the key forces fueling the demand for hormonal contraceptives around the globe. The hormonal contraceptives have emerged as a reliable and safe method for preventing unintended pregnancy. A wide range of devices and medications are used for preventing the ovulation and fertilization process with the help of continuous administration of hormones or through one-time consumption pills.
The adoption of hormonal contraceptives has witnessed prominent growth in past couple of decades owing to urbanization and increasing awareness among women of different age group. The adolescent pregnancies have increased significantly over past two decades, which has contributed significantly towards the consumption of hormonal contraceptives around the globe. Additionally, government initiatives to promote the use of hormonal contraceptives as a measure to control population explosion is aiding the growth of the global hormonal contraceptive market. The global hormonal contraceptive market is expected to grow steadily during the forecast period.
North America contributed the largest share to the global hormonal contraceptives market in 2019 and is anticipated to be a dominating geography during the forecast period. The awareness regarding sexual health is significantly high in the United States and Canada, which has contributed towards early adoption of hormonal contraceptives.
Additionally, increasing unintended pregnancies across the region, easy of availability, and presence of leading manufacturers of hormonal contraceptives are key contributors towards the growth of hormonal contraceptives market in North America. Asia Pacific is witnessing rise in awareness regarding the use of hormonal contraceptives fueled by the government initiatives to promote birth control measures, thereby fueling the growth of hormonal contraceptives market. Asia Pacific is anticipated to be a fastest growing geography during the forecast period owing to increasing adoption and expanding pharmaceutical manufacturing industry across the region.
The report titled “Hormonal Contraceptives Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global hormonal contraceptives market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
For instance, GlaxoSmithKline plc reported revenues of USD 41,974.1 million in 2019 and the product segment analysis of the company indicates that Pharmaceuticals business segment of the company dominated revenue in 2019 with North America being the largest revenue contributing geography under the Pharmaceutical business segment.
The global hormonal contraceptives market is segmented based on method of administration, type of hormone, end user, and geography. Based on method of administration, the global hormonal contraceptives market is segmented into contraceptive pills, injectable, intrauterine device (IUD), vaginal ring, transdermal patch, and others. Based on type of hormone, the global hormonal contraceptives market is segmented into progestin contraceptive and combined hormonal contraceptive. Based on sales channel, the global hormonal contraceptives market is segmented into hospitals, gynecology clinics, and others. Based on geography, the global hormonal contraceptives market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on hormonal contraceptives. Further, market share of prominent companies in the global hormonal contraceptives market would also be estimated.
For instance, GlaxoSmithKline plc operates through three business segments namely Pharmaceuticals, Vaccines, and Consumer Health. The hormonal contraceptives are delivered under Pharmaceuticals business segment of the company with revenue contribution of US$ 21860.0 million in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the hormonal contraceptives manufacturers. The global hormonal contraceptives market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the hormonal contraceptives business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global hormonal contraceptives market.
Major players active in the global hormonal contraceptives market include Ansell LTD., Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Female Health Company, HLL Lifecare Limited, Johnson & Johnson, Mayer Laboratories, Merck & Co., Inc., Mylan N.V., Pfizer, Inc., Reckitt Benckiser Plc, Teva Pharmaceutical Industries Limited, Vardhman Life Care Pvt. Ltd., V-Care Pharma Pvt. Ltd., Warner Chilcott Company, and Watson Pharmaceuticals, Inc.
Market Segmentation:
By Hormone
By Method
By Sales Channel
By Geography:
Rising awareness, increasing number of adolescent pregnancies, and government initiatives to promote hormonal contraceptives are the key forces fueling the demand for hormonal contraceptives around the globe.
The base year considered in hormonal contraceptives market report is 2022.
Key hormonal contraceptives market players are Ansell LTD., Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Female Health Company, HLL Lifecare Limited, Johnson & Johnson and others.
The global hormonal contraceptives market segmented on the basis of method of administration, type of hormone, end user, and geography.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved